These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11711263)
1. Effects of the quantity of water and milk ingested concomitantly with AS-924, a novel ester-type cephem antibiotic, on its pharmacokinetics. Matsumoto F; Sakurai I; Morita M; Takahashi T; Mori N; Sugihara T; Sakai A; Yamaji S; Akaike Y; Yano K Int J Antimicrob Agents; 2001 Nov; 18(5):471-6. PubMed ID: 11711263 [TBL] [Abstract][Full Text] [Related]
2. Effect of antacid pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic--comparison with cefteram-pivoxil. Totsuka K; Shimizu K; Mori N; Sugihara T; Sakai A; Yamaji S; Michisuji Y; Shinohara Y; Kubo A; Tokuoka H Int J Antimicrob Agents; 2001 Nov; 18(5):477-82. PubMed ID: 11711264 [TBL] [Abstract][Full Text] [Related]
3. Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil. Totsuka K; Shimizu K; Mori N; Sugihara T; Sakai A; Yamaji S; Michisuji Y; Shinohara Y; Kubo A; Tokuoka H Int J Antimicrob Agents; 2001 Nov; 18(5):463-9. PubMed ID: 11711262 [TBL] [Abstract][Full Text] [Related]
4. Effects of gastrointestinal stimulant and suppressant pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Yanagawa A; Shimada J; Mori N; Sugihara T; Sakai A; Yamaji S; Yano K; Kitamura T; Kano T Int J Antimicrob Agents; 2001 Nov; 18(5):483-7. PubMed ID: 11711265 [TBL] [Abstract][Full Text] [Related]
5. [Effects of antacids on absorption, excretion and metabolism of cefteram pivoxil]. Shimada J; Saito A; Shiba K; Kaji M; Hori S; Yoshida M; Miyahara T Jpn J Antibiot; 1990 Aug; 43(8):1353-70. PubMed ID: 2178195 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefcapene pivoxil and AS-924 in gastrectomized patients. Fujimoto M Int J Antimicrob Agents; 2001 Nov; 18(5):489-94. PubMed ID: 11711266 [TBL] [Abstract][Full Text] [Related]
7. Effect of timing of food on absorption of cefpodoxime proxetil. Borin MT; Driver MR; Forbes KK J Clin Pharmacol; 1995 May; 35(5):505-9. PubMed ID: 7657851 [TBL] [Abstract][Full Text] [Related]
9. AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity. Mori N; Kodama T; Sakai A; Suzuki T; Sugihara T; Yamaguchi S; Nishijima T; Aoki A; Toriya M; Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K Int J Antimicrob Agents; 2001 Nov; 18(5):451-61. PubMed ID: 11711261 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs. Papich MG; Davis JL; Floerchinger AM Am J Vet Res; 2010 Dec; 71(12):1484-91. PubMed ID: 21118001 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence studies of cefteram pivoxil in healthy Chinese volunteers. Wei F; Zhu R; Zhao W; Yang J; Cai Z; Hu Q Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):157-62. PubMed ID: 20166432 [TBL] [Abstract][Full Text] [Related]
12. [Clinical studies on cefteram pivoxil in pediatrics]. Yokoyama M; Yonesaka S; Aoyama R; Sudou Y Jpn J Antibiot; 1989 Aug; 42(8):1745-50. PubMed ID: 2810738 [TBL] [Abstract][Full Text] [Related]
13. AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption. Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K; Mori N; Sakai A; Sugihara T Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1081-8. PubMed ID: 10478463 [TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on cefteram pivoxil in the treatment of respiratory infections]. Yamaki K; Watanabe H; Takagi K; Suzuki R; Satake T; Arai T; Matsumoto S; Hara M; Kondo Y; Taniguchi H Jpn J Antibiot; 1990 Jan; 43(1):81-8. PubMed ID: 2190016 [TBL] [Abstract][Full Text] [Related]
15. AS-924, a novel bifunctional prodrug of ceftizoxime. Kasai M; Hatano S; Kitagawa M; Yoshimi A; Shirahase H; Nishimura K; Kakeya N J Antibiot (Tokyo); 1999 May; 52(5):491-500. PubMed ID: 10480574 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses. Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers. Tam YK; Kneer J; Dubach UC; Stoeckel K Antimicrob Agents Chemother; 1989 Jun; 33(6):957-9. PubMed ID: 2764545 [TBL] [Abstract][Full Text] [Related]
18. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Stoeckel K; Tam YK; Kneer J Curr Med Res Opin; 1989; 11(7):432-41. PubMed ID: 2673663 [TBL] [Abstract][Full Text] [Related]